← Back
Data updated: Mar 10, 2026
MEDEXUS
Oncology
MEDEXUS is a pharmaceutical company focused on Oncology. Key products include GRAFAPEX.
2014
Since
2
Drugs
-
Trials
2
Approved (2yr)
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...